Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (87)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  3. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  4. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

  5. Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115

  6. Lipin-2 regulates the antiviral and anti-inflammatory responses to interferon

    EMBO Reports, Vol. 24, Núm. 12

  7. Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial

    Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663

  8. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

    Hypertension, Vol. 80, Núm. 1, pp. 84-96

  9. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease

    Scientific Reports, Vol. 13, Núm. 1

  10. TiO2 Nanospikes Micro-Areas on Rutile Single Crystal Surfaces Determine Arrangements of Rat Aortic Vascular Smooth Muscle Cells

    Proceedings of the IEEE Conference on Nanotechnology

  11. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels

    Biomedicine and Pharmacotherapy, Vol. 161